The Diagnostic Rate and Clinical Implications of Neuron-Specific Enolase in Neuroendocrine Tumors and Small Cell Lung Cancer: Data from the Ministry of Health of the Republic of Turkey
-
Published:2023-09-27
Issue:4
Volume:61
Page:231-237
-
ISSN:1302-0072
-
Container-title:Medical Bulletin of Haseki
-
language:
-
Short-container-title:Haseki
Author:
Birinci SuayipORCID,
Ulgu Mustafa MahirORCID
Publisher
Galenos Yayinevi
Reference9 articles.
1. Isgrò MA, Bottoni P, Scatena R. Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects. Adv Exp Med Biol 2015;867:125-43.
2. Vansteenkiste JL, Crinò C, Dooms J, et al. 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up. Ann Oncol 2014;25:1462-74.
3. Temporal trends from 1986 to 2008 in overall survival of small cell lung cancer patients;Schabath;Lung Cancer,2014
4. Pro-gastrin-releasing peptide and neuron-specific enolase: useful predictors of response to chemotherapy and survival in patients with small cell lung cancer;Huang; Clin Transl Oncol,2016
5. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database;Govindan;J Clin Oncol,2006